Loading…
Revolution Medicines, Inc. is projected to rise to $195.13 by 2027, a +28% move from its current price of $153.00. RVMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $149.36 | $153.09 | $156.91 | +0.06% |
| May 30 | $147.92 | $153.18 | $158.62 | +0.12% |
| May 31 | $146.85 | $153.27 | $159.96 | +0.17% |
| Jun 1 | $145.97 | $153.36 | $161.11 | +0.23% |
| Jun 2 | $145.21 | $153.44 | $162.15 | +0.29% |
| Jun 3 | $144.53 | $153.53 | $163.10 | +0.35% |
| Jun 4 | $143.91 | $153.62 | $163.99 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $143.91 | $153.62 | $163.99 | +0.41% |
| Week 2 | $140.64 | $154.25 | $169.17 | +0.82% |
| Week 3 | $138.32 | $154.87 | $173.41 | +1.23% |
| Week 4 | $136.47 | $155.50 | $177.19 | +1.64% |
| Week 5 | $134.93 | $156.14 | $180.68 | +2.05% |
| Week 6 | $133.60 | $156.77 | $183.96 | +2.47% |
| Week 7 | $132.44 | $157.41 | $187.09 | +2.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revolution Medicines, Inc. is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers. Its RAS(ON) inhibitors bind RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers.
Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in a phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; development candidates comprise RMC-5127 (G12V) and RMC-0708 (Q61H), that are in clinical trials; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD is the stock ticker for Revolution Medicines, Inc. The current price is $151.56 and the market cap is $32.22B. The company is ranked 425 by market capitalization. The price outlook is anchored by a long-term forecast that projects a rise in average prices from 2026 through 2050, signaling meaningful upside potential over time.
The forecast shows a path of higher averages and sizable upside, with 2026 average near the current price and substantial gains projected toward 2050.
A major floor 39.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.2% away) — a breakout level to watch.
A major ceiling 10.9% above — clearing it would confirm fresh momentum.
Key RVMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $152.70 | Buy | $152.24 | Buy |
| MA 10 | $150.03 | Buy | $150.31 | Buy |
| MA 20 | $147.24 | Buy | $146.26 | Buy |
| MA 50 | $127.89 | Buy | $132.74 | Buy |
| MA 100 | $115.00 | Buy | $116.35 | Buy |
| MA 200 | $85.77 | Buy | $95.32 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.41 | Neutral |
| Stoch RSI (14) | 63.16 | Neutral |
| CCI (20) | 104.36 | Buy |
| Williams %R (14) | -14.45 | Info |
| MACD (12,26,9) | -0.51 | Sell |
| ROC (12) | 7.89 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 85.55 | Sell |
| TRIX (15) | 0.73 | Buy |
| Awesome (5,34) | 9.93 | Buy |
| Ultimate (7,14,28) | 62.58 | Neutral |
| Momentum (10) | 7.28 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 155.11 | Sell |
| ADX (14) | 24.63 | Buy |
| ATR (14) | 3.39 | Info |
Near term, the technical picture is bullish. The RSI14 is 60, with a 50-day moving average of $125.61 and a 200-day moving average of $84.58. Support is at $131.67 and resistance at $153.73. The 30-day price range runs from a low of $127.91 to a high of $179.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $78.33 | $153.00 | $220.05 | 0% | Neutral | |
| $156.20 | $195.13 | $257.34 | +28% | Bullish | |
| $173.04 | $221.47 | $301.79 | +45% | Bullish | |
| $186.46 | $243.53 | $340.57 | +59% | Bullish | |
| $190.41 | $253.19 | $361.96 | +65% | Bullish | |
| $242.92 | $328.33 | $478.52 | +115% | Bullish | |
| $286.93 | $393.76 | $583.94 | +157% | Bullish | |
| $291.61 | $405.93 | $611.58 | +165% | Bullish | |
| $323.62 | $456.64 | $698.07 | +198% | Bullish | |
| $332.64 | $475.49 | $736.79 | +211% | Bullish | |
| $521.71 | $790.71 | $1,297.13 | +417% | Bullish | |
| $998.34 | $1,671.85 | $2,982.02 | +993% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $78.33 | $153.00 | $179.63 | +0.00% |
| June 2026 | $132.24 | $154.98 | $185.70 | +1.30% |
| July 2026 | $136.60 | $161.31 | $195.66 | +4.08% |
| August 2026 | $139.91 | $166.20 | $203.49 | +3.03% |
| September 2026 | $138.41 | $165.23 | $203.85 | -0.58% |
| October 2026 | $138.95 | $166.61 | $207.00 | +0.84% |
| November 2026 | $143.38 | $172.61 | $215.75 | +3.60% |
| December 2026 | $144.86 | $175.05 | $220.05 | +1.41% |
Click any year to see its month-by-month RVMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Revolution Medicines, Inc.'s 2026 outlook centres on $153.00, within a $78.33 to $220.05 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, RVMD could reach as high as $257.34, with a base case around $195.13 and support toward $156.20 — roughly +28% from $153.00. Buyers look set to stay in control over this stretch.
Expect RVMD to range from $173.04 to $301.79 through 2028. The $221.47 average target implies a +45% move from current prices. That is up +13% on the projected 2027 average. Momentum favours further upside here.
The RVMD price prediction for 2029 points to an average of $243.53 (low $186.46, high $340.57) — a potential gain of +59% on today's $153.00. Buyers look set to stay in control over this stretch.
In 2030, RVMD is projected to trade between $190.41 and $361.96, averaging $253.19 — a potential gain of +65% from today's $153.00. That is up +4% on the projected 2029 average. Momentum favours further upside here.
Revolution Medicines, Inc.'s 2031 outlook centres on $328.33, within a $242.92 to $478.52 range. That is up +30% on the projected 2030 average. That marks a +115% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, RVMD could reach as high as $583.94, with a base case around $393.76 and support toward $286.93 — roughly +157% from $153.00. Momentum favours further upside here.
Expect RVMD to range from $291.61 to $611.58 through 2033. The $405.93 average target implies a +165% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The RVMD price prediction for 2034 points to an average of $456.64 (low $323.62, high $698.07) — a potential gain of +198% on today's $153.00. Momentum favours further upside here.
In 2035, RVMD is projected to trade between $332.64 and $736.79, averaging $475.49 — a potential gain of +211% from today's $153.00. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Revolution Medicines, Inc.'s 2040 outlook centres on $790.71, within a $521.71 to $1,297.13 range. That is up +66% on the projected 2035 average. That marks a +417% change versus current levels. Momentum favours further upside here.
By 2050, RVMD could reach as high as $2,982.02, with a base case around $1,671.85 and support toward $998.34 — roughly +993% from $153.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVMD today (≈ 6.535948 RVMD) could be worth
$10,927.14
+$9,927.14 (+993%) by 2050 · US Dollar
Based on the average projected RVMD price of $1,671.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVMDwould be worth at today's price.
$1,000 invested in RVMD on May 27, 2025 (≈ 27.045302 RVMD) would be worth
$4,137.93
+$3,137.93 (+313.8%) today · 4.14× · US Dollar
Based on a RVMD entry price of $36.97 vs. today's $153.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $150.33 | $1,017.76 | +1.8% |
| 1 month ago | $131.67 | $1,162 | +16.2% |
| 3 months ago | $102.15 | $1,497.8 | +49.8% |
| 6 months ago | $77.76 | $1,967.59 | +96.8% |
| 1 year ago | $36.97 | $4,137.93 | +313.8% |
| All time (5.0y) ago | $30.22 | $5,062.87 | +406.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVMD forecast.
Our base-case forecast reaches $310.00 around 2031.
Implied market cap at $310.00: $65.9B
The multi-year forecast indicates bullish sentiment from 2027 onward, with 2026 labeled neutral. The 2030 forecast shows an average price of $254.86 and an ROI of 68.2%; by 2040 the average is $816.01 with an ROI of 438.4%; and by 2050 the average is $1,733.38 with an ROI of 1043.7%. Across the horizon, sentiment remains bullish through 2031 ($492.45 max) and 2032 ($598.20 max), with higher projected maximums continuing into 2033 ($627.52), 2034 ($721.61), 2035 ($756.81), 2040 ($1,355.70), and 2050 ($3,138.60).
These figures are projections and not guarantees; actual results depend on market conditions and the company’s performance.
Tap a question to reveal the answer.
The forecast shows 2030 min $190.32, avg $254.86, max $367.41, with an ROI of 68.2%.
The forecast assigns a neutral sentiment in 2026 and bullish sentiment from 2027 onward, with rising averages through 2050 (e.g., avg $1,733.38 in 2050 and max $3,138.60), which suggests upside potential but is not a guarantee.
Yes. The forecast max reaches $492.45 in 2031 and $598.20 in 2032, which exceed $500.
Current price is $151.56 and market cap is $32.22B.
The sentiment is bullish with RSI 60; SMA50 is $125.61 and SMA200 is $84.58. Support is $131.67 and resistance is $153.73; the 30-day range runs from $127.91 to $179.58.
Revolution Medicines, Inc. Community Discussion
0Share your Revolution Medicines, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.